Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 74Myeloid 32Lymphoid 11Head & Neck 5Other solid neoplasm 4Dermatologic 4Thoracic 3Sarcoma 3Gynecologic 2Gastrointestinal 2CNS 2Breast 2Tumor-Agnostic 1Plasma cell 1Other neoplasm 1Genitourinary 1Classical hematology 1

Conditions

Urinary Bladder Neoplasms 1Melanoma 1Breast Neoplasms, Male 1Breast Neoplasms 1Advanced Breast Cancer 1

Interventions

Paclitaxel 100Trastuzumab 81pembrolizumab 78Fulvestrant 68Cyclophosphamide 66Carboplatin 49Capecitabine 47Docetaxel 45palbociclib 41Lapatinib 40Letrozole 37Doxorubicin 29olaparib 28Taxes 28Nivolumab 25Magnetic Resonance Spectroscopy 25Gemcitabine 25130-nm albumin-bound paclitaxel 25Everolimus 23Biopsy 23ribociclib 22abemaciclib 21Specimen Handling 21Albumin-Bound Paclitaxel 21Cisplatin 20Radiotherapy 19Bevacizumab 19Ado-Trastuzumab Emtansine 19pertuzumab 17Alpelisib 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Decitabine × Breast × Clear all
NCT03282825 2018-01-23

Clinical Study of Decitabine and Paclitaxel Combination Therapy

Dong Wha Pharmaceutical Co. Ltd.

Phase 1 Unknown
18 enrolled
Breast

Advanced Breast Cancer

NCT00030615 2013-02-07

Decitabine in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
24 enrolled
BreastDermatologicGenitourinary

Urinary Bladder Neoplasms, Breast Neoplasms, Melanoma, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡